Cargando…
MiR-143 inhibits endometrial cancer cell proliferation and metastasis by targeting MAPK1
Endometrial cancer (EC) is one of the most commonly diagnosed gynecologic malignancies in the world, with the morbidity rate of over 7%. The mechanism of the pathogenesis has not been specifically elucidated to date, which is imperative for EC treatment. The aim of our study was to investigate the t...
Autores principales: | Chang, Lei, Zhang, Dongya, Shi, Huirong, Bian, Yangyang, Guo, Ruixia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663604/ https://www.ncbi.nlm.nih.gov/pubmed/29137432 http://dx.doi.org/10.18632/oncotarget.21037 |
Ejemplares similares
-
miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6
por: Lei, Chao, et al.
Publicado: (2017) -
The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019) -
miR-143 Inhibits NSCLC Cell Growth and Metastasis by Targeting Limk1
por: Xia, Hui, et al.
Publicado: (2014) -
Loss of miR-143 and miR-145 in condyloma acuminatum promotes cellular proliferation and inhibits apoptosis by targeting NRAS
por: Liu, Xiaoyan, et al.
Publicado: (2018) -
LncRNA miR143HG Up-Regulates p53 In Endometrial Carcinoma By Sponging miR-125a
por: Shi, Fan, et al.
Publicado: (2019)